Literature DB >> 34325466

Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians.

Yuko Sato1,2,3, Koji Atarashi1,2,3, Damian R Plichta4, Yasumichi Arai5, Satoshi Sasajima1,3, Sean M Kearney1,2, Wataru Suda2, Kozue Takeshita1,3, Takahiro Sasaki6, Shoki Okamoto1, Ashwin N Skelly1, Yuki Okamura1, Hera Vlamakis4, Youxian Li2, Takeshi Tanoue1,2,3, Hajime Takei7, Hiroshi Nittono7, Seiko Narushima1,2, Junichiro Irie8, Hiroshi Itoh8, Kyoji Moriya9, Yuki Sugiura10, Makoto Suematsu10, Nobuko Moritoki11, Shinsuke Shibata11, Dan R Littman12,13, Michael A Fischbach14, Yoshifumi Uwamino15, Takashi Inoue16, Akira Honda17, Masahira Hattori2,18, Tsuyoshi Murai6, Ramnik J Xavier19,20,21, Nobuyoshi Hirose5, Kenya Honda22,23,24.   

Abstract

Centenarians have a decreased susceptibility to ageing-associated illnesses, chronic inflammation and infectious diseases1-3. Here we show that centenarians have a distinct gut microbiome that is enriched in microorganisms that are capable of generating unique secondary bile acids, including various isoforms of lithocholic acid (LCA): iso-, 3-oxo-, allo-, 3-oxoallo- and isoallolithocholic acid. Among these bile acids, the biosynthetic pathway for isoalloLCA had not been described previously. By screening 68 bacterial isolates from the faecal microbiota of a centenarian, we identified Odoribacteraceae strains as effective producers of isoalloLCA both in vitro and in vivo. Furthermore, we found that the enzymes 5α-reductase (5AR) and 3β-hydroxysteroid dehydrogenase (3β-HSDH) were responsible for the production of isoalloLCA. IsoalloLCA exerted potent antimicrobial effects against Gram-positive (but not Gram-negative) multidrug-resistant pathogens, including Clostridioides difficile and Enterococcus faecium. These findings suggest that the metabolism of specific bile acids may be involved in reducing the risk of infection with pathobionts, thereby potentially contributing to the maintenance of intestinal homeostasis.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34325466     DOI: 10.1038/s41586-021-03832-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1 in total

1.  A Cross-Sectional Study of Compositional and Functional Profiles of Gut Microbiota in Sardinian Centenarians.

Authors:  David J Kelvin; Ciriaco Carru; Lu Wu; Tiansheng Zeng; Angelo Zinellu; Salvatore Rubino
Journal:  mSystems       Date:  2019-07-09       Impact factor: 6.496

  1 in total
  45 in total

Review 1.  Measuring biological age using omics data.

Authors:  Jarod Rutledge; Hamilton Oh; Tony Wyss-Coray
Journal:  Nat Rev Genet       Date:  2022-06-17       Impact factor: 53.242

Review 2.  Microbiota succession throughout life from the cradle to the grave.

Authors:  Cameron Martino; Amanda Hazel Dilmore; Zachary M Burcham; Jessica L Metcalf; Dilip Jeste; Rob Knight
Journal:  Nat Rev Microbiol       Date:  2022-07-29       Impact factor: 78.297

Review 3.  New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease.

Authors:  Yali Liu; Tao Liu; Xu Zhao; Yanhang Gao
Journal:  Cell Mol Life Sci       Date:  2022-08-17       Impact factor: 9.207

4.  Anti-infective bile acids bind and inactivate a Salmonella virulence regulator.

Authors:  Xinglin Yang; Kathryn R Stein; Howard C Hang
Journal:  Nat Chem Biol       Date:  2022-09-29       Impact factor: 16.174

5.  RiboTaxa: combined approaches for rRNA genes taxonomic resolution down to the species level from metagenomics data revealing novelties.

Authors:  Oshma Chakoory; Sophie Comtet-Marre; Pierre Peyret
Journal:  NAR Genom Bioinform       Date:  2022-09-21

Review 6.  Untangling the oral-gut axis in the pathogenesis of intestinal inflammation.

Authors:  Sho Kitamoto; Nobuhiko Kamada
Journal:  Int Immunol       Date:  2022-09-06       Impact factor: 5.071

Review 7.  Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

Authors:  Jie Cai; Lulu Sun; Frank J Gonzalez
Journal:  Cell Host Microbe       Date:  2022-03-09       Impact factor: 21.023

8.  Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.

Authors:  Svetlana F Lima; Lasha Gogokhia; Monica Viladomiu; Lance Chou; Gregory Putzel; Wen-Bing Jin; Silvia Pires; Chun-Jun Guo; Ylaine Gerardin; Carl V Crawford; Vinita Jacob; Ellen Scherl; Su-Ellen Brown; John Hambor; Randy S Longman
Journal:  Gastroenterology       Date:  2021-10-02       Impact factor: 22.682

9.  The inhibition of enterocyte proliferation by lithocholic acid exacerbates necrotizing enterocolitis through downregulating the Wnt/β-catenin signalling pathway.

Authors:  Zhoushan Feng; Chunhong Jia; Xiaojun Lin; Hu Hao; Sitao Li; Fei Li; Qiliang Cui; Yaoyong Chen; Fan Wu; Xin Xiao
Journal:  Cell Prolif       Date:  2022-04-20       Impact factor: 8.755

10.  Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.

Authors:  Jingpeng Yang; Hong Yang; Lingtong Meng
Journal:  Microbiol Spectr       Date:  2022-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.